Epilepsy pipeline conference
Come Join Us!
Interested in epilepsy treatment, therapeutic innovation, and product development? Join us at the Epilepsy Foundation Pipeline Conference, March 12-13, 2020. (To be rescheduled)
The Epilepsy Foundations Pipeline Conference brings together decision makers with a stake in the field of epilepsy treatment, therapeutic innovation, and product development.
Join NeuCyte's Presentations
This is a first-in-class drug candidate for treating refractory epilepsy with unique MoA. It shows superior and broad efficacy and preclinical safety profiles, and better anti-seizure efficacy than benchmark AEDs in 11 epilepsy animal models. It’s gained NIH “Red Book” status and been highly anticipated by epilepsy researchers and neurologists.
This presentation will be included in Session V, Day 1.
Date: March 12, 2020 (To be rescheduled)
Session Title: What We Still Need in Drugs for Focal Epilepsy
Session Time: 1:55 pm
Hui Liu PhD, Director, Drug Discovery, NeuCyte
Based on its proprietary technology for generating human iPSC-derived induced neuronal cells, NeuCyte has developed an in vitro human neural platform for complex electrophysiological and morphological readouts suited for target identification and validation, efficacy testing, and neurotoxicity assessment. Using patient-derived and genetically engineered defined neural cell types, NeuCyte builds unique cell-based assays for modeling neurological and neurodegenerative disorders.
This presentation will be included in Session VI, Day 2.
Date: March 13, 2020 (To be rescheduled)
Session Title: Screening
Session Time: 8:15 am
Thomas Portmann PhD,
Head of Research, NeuCyte
Every two years, The Epilepsy Foundation hosts a one-day educational conference dedicated to people with epilepsy, their families and friends, and community supporters. Learn about #CommunityDay2020 on March 14 in Santa Clara, CA: epilepsy.com/CommunityDay2020